Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Salmon

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Neuropathology and Applied Neurobiology|March 29, 2000
Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumoursI Camby, F Lefranc, G Titeca, et al.
Biotechnology and Bioengineering|December 20, 1995
N-glycans of recombinant human interferon-gamma change during batch culture of chinese hamster ovary cellsA D Hooker, M H Goldman, N H Markham, et al.
Journal of Neuro-Oncology|October 9, 2017
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.
Journal of Neuropathology and Experimental Neurology|February 24, 2001
Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomasI Camby, C Decaestecker, L Gordower, et al.
Brain Pathology (Zurich, Switzerland)|January 6, 2001
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migrationI Camby, N Belot, S Rorive, et al.
Glia|March 10, 2001
Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchymaS Rorive, N Belot, C Decaestecker, et al.
Brain Pathology (Zurich, Switzerland)|February 16, 1999
Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteinsI Camby, N Nagy, M B Lopes, et al.
British Journal of Cancer|June 13, 2015
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisL De Smedt, J Lemahieu, S Palmans, et al.
Gut|February 13, 2002
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressorN Nagy, Y Bronckart, I Camby, et al.
Diabetologia|April 10, 2010
A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarkerD Flamez, I Roland, A Berton, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Neuropathology and Applied Neurobiology|March 29, 2000
Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumoursI Camby, F Lefranc, G Titeca, et al.
Biotechnology and Bioengineering|December 20, 1995
N-glycans of recombinant human interferon-gamma change during batch culture of chinese hamster ovary cellsA D Hooker, M H Goldman, N H Markham, et al.
Journal of Neuro-Oncology|October 9, 2017
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.
Journal of Neuropathology and Experimental Neurology|February 24, 2001
Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomasI Camby, C Decaestecker, L Gordower, et al.
Brain Pathology (Zurich, Switzerland)|January 6, 2001
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migrationI Camby, N Belot, S Rorive, et al.
Glia|March 10, 2001
Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchymaS Rorive, N Belot, C Decaestecker, et al.
Brain Pathology (Zurich, Switzerland)|February 16, 1999
Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteinsI Camby, N Nagy, M B Lopes, et al.
British Journal of Cancer|June 13, 2015
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisL De Smedt, J Lemahieu, S Palmans, et al.
Gut|February 13, 2002
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressorN Nagy, Y Bronckart, I Camby, et al.
Diabetologia|April 10, 2010
A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarkerD Flamez, I Roland, A Berton, et al.
Pageof 21